|4Jan 29, 9:03 PM ET

Day Wesley 4

4 · VIVUS INC · Filed Jan 29, 2013

Insider Transaction Report

Form 4
Period: 2013-01-25
Day Wesley
VP, Clinical Research
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2013-01-25+8,1008,100 total
    Exercise: $12.39Exp: 2023-01-25Common Stock (8,100 underlying)
  • Award

    Non-Qualified Stock Option (right to buy)

    2013-01-25+41,90041,900 total
    Exercise: $12.39Exp: 2023-01-25Common Stock (41,900 underlying)
Holdings
  • Common Stock

    1,052
Footnotes (2)
  • [F1]Includes 1,052 shares acquired under the VIVUS, Inc. Employee Stock Purchase Plan on November 14, 2012.
  • [F2]Twenty-five percent (25%) of the total number of shares become exercisable on 1/25/2014 and one forty-eighth (1/48th) of the total number of shares become exercisable on the 25th of each month thereafter.

Documents

1 file
  • 4
    a4.xmlPrimary

    4